Company intelligence / Profile preview

Clivi

Ownership: Private
Development stage: Commercial

Overview

Clivi is an active Mexico-based digital clinic specializing in comprehensive treatment for patients with type 2 diabetes. Since launching in October 2021, it has helped thousands of patients achieve improved glycemic control—94% of users have achieved diabetes control within six months. The company combines access to endocrinologists, nutritionists, psychologists, remote monitoring via WhatsApp and other channels, and supplies such as glucometers and medications. It reports $2 million annual recurring revenue over the past 15 months with rapid growth.

Therapeutic areas: Endocrinology
Modalities: Non-pharmacological therapyDeviceSmall molecule
Industry: Non-Academic Healthcare

Partnerships

No major pharmaceutical or biotech partnerships disclosed; works with private insurance providers to lower patient costs

Beyond the preview

Go deeper on Clivi.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clivi.

Explore the full profile